Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Chan

Showing results (451-460 of 509) with videos related to

Pageof 51
Sort By:
Vaccines|March 28, 2024
Pregnancy Outcomes among Pregnant Persons after COVID-19 Vaccination: Assessing Vaccine Safety in Retrospective Cohort Analysis of U.S. National COVID Cohort Collaborative (N3C)Emily A G Faherty, Kenneth J Wilkins, Sara Jones, et al.
Insights Into Imaging|October 25, 2017
Body composition determinants of radiation dose during abdominopelvic CTPatrick D McLaughlin, Liam Chawke, Maria Twomey, et al.
Nature Cell Biology|June 15, 2026
Integrated stress response couples mitochondrial fitness with lineage reprogramming to drive cancer evolutionShiqi Diao, Jia Yi Zou, Shuo Wang, et al.
Translational Psychiatry|June 8, 2024
Association of post-COVID phenotypic manifestations with new-onset psychiatric diseaseBen Coleman, Elena Casiraghi, Tiffany J Callahan, et al.
American Journal of Physiology. Cell Physiology|December 3, 2010
Increased matriptase zymogen activation in inflammatory skin disordersCheng-Jueng Chen, Bai-Yao Wu, Pai-In Tsao, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|September 15, 2022
Meta-analysis of the Placebo and Nocebo effects associated with Placebo treatment in randomized trials of lipid-lowering therapiesYip H Chin, Oliver Lim, Chaoxing Lin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2013
Final results from a randomized phase 3 study of FOLFIRI {+/-} panitumumab for second-line treatment of metastatic colorectal cancerM Peeters, T J Price, A Cervantes, et al.
Environmental Health Perspectives|December 28, 2020
Community Approaches for Integrating Environmental Exposures into Human Models of DiseaseAnne E Thessen, Cynthia J Grondin, Resham D Kulkarni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2017
Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with recurrent carcinoma of the anal canalP A Ott, S A Piha-Paul, P Munster, et al.
Oncogene|December 2, 2010
A Variant in a MicroRNA complementary site in the 3' UTR of the KIT oncogene increases risk of acral melanomaS E Godshalk, T Paranjape, S Nallur, et al.
Pageof 51

Showing results (451-460 of 509) with videos related to

Sort By:
Pageof 51
Vaccines|March 28, 2024
Pregnancy Outcomes among Pregnant Persons after COVID-19 Vaccination: Assessing Vaccine Safety in Retrospective Cohort Analysis of U.S. National COVID Cohort Collaborative (N3C)Emily A G Faherty, Kenneth J Wilkins, Sara Jones, et al.
Insights Into Imaging|October 25, 2017
Body composition determinants of radiation dose during abdominopelvic CTPatrick D McLaughlin, Liam Chawke, Maria Twomey, et al.
Nature Cell Biology|June 15, 2026
Integrated stress response couples mitochondrial fitness with lineage reprogramming to drive cancer evolutionShiqi Diao, Jia Yi Zou, Shuo Wang, et al.
Translational Psychiatry|June 8, 2024
Association of post-COVID phenotypic manifestations with new-onset psychiatric diseaseBen Coleman, Elena Casiraghi, Tiffany J Callahan, et al.
American Journal of Physiology. Cell Physiology|December 3, 2010
Increased matriptase zymogen activation in inflammatory skin disordersCheng-Jueng Chen, Bai-Yao Wu, Pai-In Tsao, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|September 15, 2022
Meta-analysis of the Placebo and Nocebo effects associated with Placebo treatment in randomized trials of lipid-lowering therapiesYip H Chin, Oliver Lim, Chaoxing Lin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2013
Final results from a randomized phase 3 study of FOLFIRI {+/-} panitumumab for second-line treatment of metastatic colorectal cancerM Peeters, T J Price, A Cervantes, et al.
Environmental Health Perspectives|December 28, 2020
Community Approaches for Integrating Environmental Exposures into Human Models of DiseaseAnne E Thessen, Cynthia J Grondin, Resham D Kulkarni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2017
Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with recurrent carcinoma of the anal canalP A Ott, S A Piha-Paul, P Munster, et al.
Oncogene|December 2, 2010
A Variant in a MicroRNA complementary site in the 3' UTR of the KIT oncogene increases risk of acral melanomaS E Godshalk, T Paranjape, S Nallur, et al.
Pageof 51